MEGAN HUNTER: Open Payments
NPI 1649753617 · BINGHAM FARMS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 41 payments from 9 companies in 2025. Trend: 2023 $1,271 · 2024 $1,494 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $172 |
| Janssen Biotech, Inc. | 7 | $150 |
| UCB, Inc. | 7 | $145 |
| LEO Pharma Inc. | 5 | $93 |
| ABBVIE INC. | 3 | $78 |
| KYOWA KIRIN, INC. | 3 | $72 |
| Organon LLC | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: NEMLUVIO, TREMFYA, Bimzelx, POTELIGEO, RINVOQ, SPEVIGO, ADBRY, VTAMA.
Industry payments across MI — which companies pay providers there.
